Heart diseases

Focus on cardiometabolic matters

2020; 21(11 Suppl): 14-17

Diabetic kidney disease and CVD

JAKOB APPEL ØSTERGAARD, MARK E. COOPER

Focus on cardiometabolic matters

2020; 21(11 Suppl): 4-12

Dyslipidaemia in type 2 diabetes: cardiovascular risk assessment and management

NICK S.R. LAN, Kharis Burns, DAMON A. BELL, GERALD F. WATTS

Obesity awareness collection. Part 3

September 2020

The cardiac complications of obesity

Elizabeth Paratz, Sonny Palmer, Justin Mariani

2020; 21(6): 14-20

Screening for atrial fibrillation: the essential role of GPs

KATRINA GISKES, CHARLOTTE HESPE, BEN FREEDMAN

2020; 21(2): 30-36

How to optimise therapy for heart failure with reduced ejection fraction

Andrew Sindone, ANDREA DRISCOLL

2020; 21(2): 12-17

Pulmonary hypertension – when to suspect and refer

ALAN M. CAREW, JOHN FEENSTRA

2020; 21(1): 30-33

Comorbidities in heart failure

ANITA SHARMA, INGRID HOPPER

2020; 21(1): 12-22

Closing the gap for women with coronary artery disease

LOUISE SEGAN, SONYA BURGESS, SARAH ZAMAN

Focus on heart failure

2019; 20(10 Suppl): 33-40

What’s on the horizon for heart failure management?

Peter MacDonald, SCOTT MCKENZIE

Focus on heart failure

2019; 20(10 Suppl): 17-21

Comorbidities in heart failure

ANITA SHARMA, INGRID HOPPER

Focus on heart failure

2019; 20(10 Suppl): 11-16

Diagnosis of heart failure

CARMINE G DE PASQUALE, RALPH G AUDEHM

Focus on heart failure

2019; 20(10 Suppl): 2-10

Heart failure guidelines - a concise summary for the GP

JOHN J. ATHERTON, RALPH AUDEHM, CIA CONNELL

2018; 19(8): 14-24

Syncope: benign or sinister?

GAUTAM VADDADI

Emergency medicine

2018; 19(2): 45-47

A routine ECG during a routine health check

Sascha Fulde, Gordian Fulde

Drug update

2016; 17(11): 63-65

Idarucizumab: an anticoagulant reversal agent for dabigatran

Anthony FT Brown, Harshal Nandurkar

2015; 16(11): 34-40

The cardiac complications of obesity

Elizabeth Paratz, Sonny Palmer, Justin Mariani

Clinical investigations from the RACP

2015; 16(10): 43-47

The patient with palpitations: cardiac, systemic or psychosomatic?

Liang-han Ling, Peter Kistler

2015; 16(7): 25-32

Practical use of the nonvitamin K antagonist oral anticoagulants

Alex Madden, Harry Gibbs

2015; 16(6): 26-34

A guide to peripheral oedema

Gayathri Kumarasinghe, Gerard Carroll

2015; 16(6): 14-24

NOACs in cardiovascular disease: what is their role?

Jyotsna Janardan, Harry Gibbs

2015; 16(5): 46-53

Diabetes and CVD risk in women. Optimising outcomes

Bethany Crinall, Sophia Zoungas

2015; 16(4): 12-22

Managing heart failure: the key role of the GP

Alex Voskoboinik, Justin Mariani

GP emergency management

2015; 5(1): 39-40

Depression after mitral valve replacement

Vivienne Miller

2014; 15(5): 34-40

Ambulatory blood pressure monitoring: beyond the simple BP

Patrick G Lan, Adrian G Gillin

2014; 15(4): 49-52

Effective ways to prevent recurrence of acute coronary syndrome

Julie Redfern, Tom Briffa, Rohina Joshi

Pages